tiprankstipranks
Advertisement
Advertisement

DCTH Stock Latest News

Delcath Systems announces ASCO 2026 investigator initiated trials-in-progress
The FlyDelcath Systems announces ASCO 2026 investigator initiated trials-in-progress
8d ago
DCTH
Delcath Shareholders Approve Expanded Equity Plan and Governance
PremiumCompany Announcements
Delcath Shareholders Approve Expanded Equity Plan and Governance
20d ago
8K
DCTH
Delcath Systems Balances Growth with Rising Costs
PremiumCompany Announcements
Delcath Systems Balances Growth with Rising Costs
25d ago
DCTH
Delcath Systems presents new data on M-PHP at ESMO
PremiumThe Fly
Delcath Systems presents new data on M-PHP at ESMO
27d ago
DCTH
Delcath Systems reports Q1 EPS (3c), consensus (9c)
PremiumThe Fly
Delcath Systems reports Q1 EPS (3c), consensus (9c)
27d ago
DCTH
Delcath Systems backs FY26 revenue view at least $100M, consensus $102.69M
PremiumThe FlyDelcath Systems backs FY26 revenue view at least $100M, consensus $102.69M
27d ago
DCTH
DCTH Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
DCTH Earnings this Week: How Will it Perform?
29d ago
DCTH
Delcath announces Chemosat Hepatic system recommended for liver treatment
Premium
The Fly
Delcath announces Chemosat Hepatic system recommended for liver treatment
2M ago
DCTH
Delcath Systems management to meet with Craig Hallum
PremiumThe Fly
Delcath Systems management to meet with Craig Hallum
2M ago
DCTH
Delcath Systems Charts Profitable Path Amid Heavy Investment
PremiumCompany Announcements
Delcath Systems Charts Profitable Path Amid Heavy Investment
3M ago
DCTH
Delcath Highlights CHOPIN Phase 2 Results in Uveal Melanoma
PremiumCompany Announcements
Delcath Highlights CHOPIN Phase 2 Results in Uveal Melanoma
3M ago
8K
DCTH
Delcath Systems publishes results from CHOPIN trial in The Lancet Oncology
PremiumThe Fly
Delcath Systems publishes results from CHOPIN trial in The Lancet Oncology
3M ago
DCTH
Delcath Systems: Procedure-Driven Growth, Pricing Power, and CHOPIN Trial Catalysts Support Buy Rating
PremiumRatingsDelcath Systems: Procedure-Driven Growth, Pricing Power, and CHOPIN Trial Catalysts Support Buy Rating
3M ago
DCTH
Delcath Systems price target lowered to $27 from $29 at Clear Street
Premium
The Fly
Delcath Systems price target lowered to $27 from $29 at Clear Street
3M ago
DCTH
Delcath Systems reports Q4 EPS (5c), consensus (3c)
Premium
The Fly
Delcath Systems reports Q4 EPS (5c), consensus (3c)
3M ago
DCTH
Delcath Systems sees FY26 revenue at least $100M, consensus $110.56M
PremiumThe Fly
Delcath Systems sees FY26 revenue at least $100M, consensus $110.56M
3M ago
DCTH
Is DCTH a Buy, Before Earnings?
PremiumPre-Earnings
Is DCTH a Buy, Before Earnings?
3M ago
DCTH
Delcath Systems Reports Strong Preliminary 2025 Results
PremiumCompany Announcements
Delcath Systems Reports Strong Preliminary 2025 Results
5M ago
8K
DCTH
Delcath Systems: Strong Hepzato Momentum and Center Expansion Drive Buy Rating and $30 Target Despite Execution and Clinical Risks
PremiumRatings
Delcath Systems: Strong Hepzato Momentum and Center Expansion Drive Buy Rating and $30 Target Despite Execution and Clinical Risks
5M ago
DCTH
Delcath Systems price target raised to $29 from $28 at Clear Street
PremiumThe FlyDelcath Systems price target raised to $29 from $28 at Clear Street
5M ago
DCTH
Delcath Systems reports preliminary Q4 revenue $20.7M, consensus $19.99M
Premium
The Fly
Delcath Systems reports preliminary Q4 revenue $20.7M, consensus $19.99M
5M ago
DCTH
Delcath Systems publishes results from subgroup analyses of FOCUS study
Premium
The Fly
Delcath Systems publishes results from subgroup analyses of FOCUS study
5M ago
DCTH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >